Effects of human Werner helicase on intrachromosomal homologous recombination mediated DNA deletions in mice

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 644, Issue 1-2, 2008, Pages 11-16

  Yamamoto, Mitsuko L ^a   Reliene, Ramune ^a   Oshima, Junko ^b   Schiestl, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

4 Nitroquinoline 1 oxide; Buthionine sulfoximine; DNA deletions; Homologous recombination; Werner syndrome; WRN

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; BUTHIONINE SULFOXIMINE; GLUTATHIONE; HELICASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA ADDUCT; DNA DAMAGE; GENE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; TRANSGENIC MOUSE; WERNER GENE; WERNER SYNDROME;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; BUTHIONINE SULFOXIMINE; DISEASE MODELS, ANIMAL; DNA; DNA DAMAGE; DNA REPAIR; EXODEOXYRIBONUCLEASES; FEMALE; GENOMIC INSTABILITY; GLUTATHIONE; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OXIDATIVE STRESS; PIGMENT EPITHELIUM OF EYE; PREGNANCY; RECOMBINATION, GENETIC; RECQ HELICASES; SEQUENCE DELETION; WERNER SYNDROME;

MUS; MUS MUSCULUS;

EID: 49649121672     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.06.008     Document Type: Article

References (59)

1. Epstein C.J., Martin G.M., Schultz A.L., and Motulsky A.G. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 45 (1966) 177-221
2. Ostler E.L., Wallis C.V., Sheerin A.N., and Faragher R.G. A model for the phenotypic presentation of Werner's syndrome. Exp. Gerontol. 37 (2002) 285-292
3. Hoehn H., Bryant E.M., Au K., Norwood T.H., Boman H., and Martin G.M. Variegated translocation mosaicism in human skin fibroblast cultures. Cytogenet. Cell Genet. 15 (1975) 282-298
4. Salk D., Au K., Hoehn H., and Martin G.M. Cytogenetics of Werner's syndrome cultured skin fibroblasts: variegated translocation mosaicism. Cytogenet. Cell Genet. 30 (1981) 92-107
5. Fukuchi K., Martin G.M., and Monnat Jr. R.J. Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5893-5897
6. Fukuchi K., Tanaka K., Kumahara Y., Marumo K., Pride M.B., Martin G.M., and Monnat Jr. R.J. Increased frequency of 6-thioguanine-resistant peripheral blood lymphocytes in Werner syndrome patients. Hum. Genet. 84 (1990) 249-252
7. Gebhart E., Bauer R., Raub U., Schinzel M., Ruprecht K.W., and Jonas J.B. Spontaneous and induced chromosomal instability in Werner syndrome. Hum. Genet. 80 (1988) 135-139
8. Ogburn C.E., Oshima J., Poot M., Chen R., Hunt K.E., Gollahon K.A., Rabinovitch P.S., and Martin G.M. An apoptosis-inducing genotoxin differentiates heterozygotic carriers for Werner helicase mutations from wild-type and homozygous mutants. Hum. Genet. 101 (1997) 121-125
9. Grigorova M., Balajee A.S., and Natarajan A.T. Spontaneous and X-ray-induced chromosomal aberrations in Werner syndrome cells detected by FISH using chromosome-specific painting probes. Mutagenesis 15 (2000) 303-310
10. Kashino G., Kodama S., Suzuki K., Matsumoto T., and Watanabe M. Exogenous expression of exonuclease domain-deleted WRN interferes with the repair of radiation-induced DNA damages. J. Radiat. Res. (Tokyo) 46 (2005) 407-414
11. A. Blank, M.S. Bobola, B. Gold, S. Varadarajan, D.K. D, E.H. Meade, P.S. Rabinovitch, L.A. Loeb, J.R. Silber, The Werner syndrome protein confers resistance to the DNA lesions N3-methyladenine and O6-methylguanine: implications for WRN function, DNA Repair (Amst) 3 (2004) 629-638.
12. Harrigan J.A., Wilson III D.M., Prasad R., Opresko P.L., Beck G., May A., Wilson S.H., and Bohr V.A. The Werner syndrome protein operates in base excision repair and cooperates with DNA polymerase beta. Nucleic Acids Res. 34 (2006) 745-754
13. Poot M., Gollahon K.A., Emond M.J., Silber J.R., and Rabinovitch P.S. Werner syndrome diploid fibroblasts are sensitive to 4-nitroquinoline-N-oxide and 8-methoxypsoralen: implications for the disease phenotype. FASEB J. 16 (2002) 757-758
14. Zhang N., Kaur R., Lu X., Shen X., Li L., and Legerski R.J. The Pso4 mRNA splicing and DNA repair complex interacts with WRN for processing of DNA interstrand cross-links. J. Biol. Chem. 280 (2005) 40559-40567
15. Lebel M., and Leder P. A deletion within the murine Werner syndrome helicase induces sensitivity to inhibitors of topoisomerase and loss of cellular proliferative capacity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13097-13102
16. Pichierri P., Franchitto A., Mosesso P., and Palitti F. Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle. Mol. Biol. Cell 12 (2001) 2412-2421
17. Hickson I.D. RecQ helicases: caretakers of the genome. Nat. Rev. Cancer 3 (2003) 169-178
18. Sharma S., Doherty K.M., and Brosh Jr. R.M. Mechanisms of RecQ helicases in pathways of DNA metabolism and maintenance of genomic stability. Biochem. J. 398 (2006) 319-337
19. Gray M.D., Shen J.C., Kamath-Loeb A.S., Blank A., Sopher B.L., Martin G.M., Oshima J., and Loeb L.A. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17 (1997) 100-103
20. Shen J.C., Gray M.D., Oshima J., Kamath-Loeb A.S., Fry M., and Loeb L.A. Werner syndrome protein. I. DNA helicase and dna exonuclease reside on the same polypeptide. J. Biol. Chem. 273 (1998) 34139-34144
21. Lee J.W., Harrigan J., Opresko P.L., and Bohr V.A. Pathways and functions of the Werner syndrome protein. Mech. Ageing Dev. 126 (2005) 79-86
22. Brosh Jr. R.M., and Bohr V.A. Human premature aging, DNA repair and RecQ helicases. Nucleic Acids Res. 35 (2007) 7527-7544
23. Pagano G., Zatterale A., Degan P., d'Ischia M., Kelly F.J., Pallardo F.V., and Kodama S. Multiple involvement of oxidative stress in Werner syndrome phenotype. Biogerontology 6 (2005) 233-243
24. Pagano G., Zatterale A., Degan P., d'Ischia M., Kelly F.J., Pallardo F.V., Calzone R., Castello G., Dunster C., Giudice A., Kilinc Y., Lloret A., Manini P., Masella R., Vuttariello E., and Warnau M. In vivo prooxidant state in Werner syndrome (WS): results from three WS patients and two WS heterozygotes. Free Radic. Res. 39 (2005) 529-533
25. Massip L., Garand C., Turaga R.V., Deschenes F., Thorin E., and Lebel M. Increased insulin, triglycerides, reactive oxygen species, and cardiac fibrosis in mice with a mutation in the helicase domain of the Werner syndrome gene homologue. Exp. Gerontol. (2005)
26. Szekely A.M., Bleichert F., Numann A., Van Komen S., Manasanch E., Ben Nasr A., Canaan A., and Weissman S.M. Werner protein protects nonproliferating cells from oxidative DNA damage. Mol. Cell Biol. 25 (2005) 10492-10506
27. Griffith O.W. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 257 (1982) 13704-13712
28. Wu G., Fang Y.Z., Yang S., Lupton J.R., and Turner N.D. Glutathione metabolism and its implications for health. J. Nutr. 134 (2004) 489-492
29. Reliene R., and Schiestl R.H. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice. Carcinogenesis 27 (2006) 240-244
30. Nunoshiba T., and Demple B. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide. Cancer Res. 53 (1993) 3250-3252
31. Yamamoto K., Inoue S., and Kawanishi S. Site-specific DNA damage and 8-hydroxydeoxyguanosine formation by hydroxylamine and 4-hydroxyaminoquinoline 1-oxide in the presence of Cu(II): role of active oxygen species. Carcinogenesis 14 (1993) 1397-1401
32. Frenzilli G., Bosco E., and Barale R. Validation of single cell gel assay in human leukocytes with 18 reference compounds. Mutat. Res. 468 (2000) 93-108
33. Ribeiro D.A., Favero Salvadori D.M., da Silva R.N., Ribeiro Darros B., and Alencar M.E. Marques Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Oral Oncol. 40 (2004) 910-915
34. Tada M. Main binding sites of the carcinogen, 4-nitroquinoline 1-oxide in nucleic acids. Biochim. Biophys. Acta 454 (1976) 558-566
35. Wang L., Ogburn C.E., Ware C.B., Ladiges W.C., Youssoufian H., Martin G.M., and Oshima J. Cellular Werner phenotypes in mice expressing a putative dominant-negative human WRN gene. Genetics 154 (2000) 357-362
36. Wu J., He J., and Mountz J.D. Effect of age and apoptosis on the mouse homologue of the huWRN gene. Mech. Ageing Dev. 103 (1998) 27-44
37. Schiestl R.H., Aubrecht J., Khogali F., and Carls N. Carcinogens induce reversion of the mouse pink-eyed unstable mutation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 4576-4581
38. Reliene R., Bishop A.J., Aubrecht J., and Schiestl R.H. In vivo DNA deletion assay to detect environmental and genetic predisposition to cancer. Methods Mol. Biol. 262 (2004) 125-139
39. Lebel M. Increased frequency of DNA deletions in pink-eyed unstable mice carrying a mutation in the Werner syndrome gene homologue. Carcinogenesis 23 (2002) 213-216
40. Nakayama A., Nguyen M.T., Chen C.C., Opdecamp K., Hodgkinson C.A., and Arnheiter H. Mutations in microphthalmia, the mouse homolog of the human deafness gene MITF, affect neuroepithelial and neural crest-derived melanocytes differently. Mech. Dev. 70 (1998) 155-166
41. Kong Y., Usuda N., and Nagata T. Radioautographic study on DNA synthesis of the retina and retinal pigment epithelium of developing mouse embryos. Cell Mol. Biol. 38 (1992) 263-272
42. Sun J.D., Ragsdale S.S., Benson J.M., and Henderson R.F. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine. Fundam. Appl. Toxicol. 5 (1985) 913-919
43. Nomura T., Okamoto E., Tateishi N., Kimura S., and Isa Y. Tumor induction in the progeny of mice receiving 4-nitroquinoline 1-oxide and N-methyl-N-nitrosourethan during pregnancy or lactation. Cancer Res. 34 (1974) 3373-3378
44. Bishop A.J., Kosaras B., Sidman R.L., and Schiestl R.H. Benzo(a)pyrene and X-rays induce reversions of the pink-eyed unstable mutation in the retinal pigment epithelium of mice. Mutat. Res. 457 (2000) 31-40
45. Huang Z., Komninou D., Kleinman W., Pinto J.T., Gilhooly E.M., Calcagnotto A., and Richie Jr. J.P. Enhanced levels of glutathione and protein glutathiolation in rat tongue epithelium during 4-NQO-induced carcinogenesis. Int. J. Cancer 120 (2007) 1396-1401
46. Jonkers J., and Berns A. Conditional mouse models of sporadic cancer. Nat. Rev. Cancer 2 (2002) 251-265
47. Blaisdell J.O., and Wallace S.S. Abortive base-excision repair of radiation-induced clustered DNA lesions in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7426-7430
48. Green R.M., Graham M., O'Donovan M.R., Chipman J.K., and Hodges N.J. Subcellular compartmentalization of glutathione: correlations with parameters of oxidative stress related to genotoxicity. Mutagenesis 21 (2006) 383-390
49. Meister A. Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta 1271 (1995) 35-42
50. Olive P.L., and Johnston P.J. DNA damage from oxidants: influence of lesion complexity and chromatin organization. Oncol. Res. 9 (1997) 287-294
51. Kyng K.J., May A., Stevnsner T., Becker K.G., Kolvra S., and Bohr V.A. Gene expression responses to DNA damage are altered in human aging and in Werner Syndrome. Oncogene 24 (2005) 5026-5042
52. Galli A., and Schiestl R.H. Effects of DNA double-strand and single-strand breaks on intrachromosomal recombination events in cell-cycle-arrested yeast cells. Genetics 149 (1998) 1235-1250
53. Saleh-Gohari N., and Helleday T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res. 32 (2004) 3683-3688
54. Kamath-Loeb A.S., Loeb L.A., Johansson E., Burgers P.M., and Fry M. Interactions between the Werner syndrome helicase and DNA polymerase delta specifically facilitate copying of tetraplex and hairpin structures of the d(CGG)n trinucleotide repeat sequence. J. Biol. Chem. 276 (2001) 16439-16446
55. Rodriguez-Lopez A.M., Jackson D.A., Iborra F., and Cox L.S. Asymmetry of DNA replication fork progression in Werner's syndrome. Aging Cell 1 (2002) 30-39
56. Machwe A., Xiao L., Groden J., and Orren D.K. The Werner and Bloom syndrome proteins catalyze regression of a model replication fork. Biochemistry 45 (2006) 13939-13946
57. Choudhary S., Doherty K.M., Handy C.J., Sayer J.M., Yagi H., Jerina D.M., and Brosh Jr. R.M. Inhibition of Werner syndrome helicase activity by benzo[a]pyrene diol epoxide adducts can be overcome by replication protein A. J. Biol. Chem. 281 (2006) 6000-6009
58. Sharma S., Otterlei M., Sommers J.A., Driscoll H.C., Dianov G.L., Kao H.I., Bambara R.A., and Brosh Jr. R.M. WRN helicase and FEN-1 form a complex upon replication arrest and together process branchmigrating DNA structures associated with the replication fork. Mol. Biol. Cell 15 (2004) 734-750
59. Rodriguez-Lopez A.M., Whitby M.C., Borer C.M., Bachler M.A., and Cox L.S. Correction of proliferation and drug sensitivity defects in the progeroid Werner's Syndrome by Holliday junction resolution. Rejuvenation Res. 10 (2007) 27-40